InvestorsHub Logo
Followers 20
Posts 1632
Boards Moderated 0
Alias Born 11/10/2010

Re: None

Thursday, 06/15/2017 11:46:30 AM

Thursday, June 15, 2017 11:46:30 AM

Post# of 20689
Synthon / Pfizer?

Its hard to get a read on where these two are with their generic being that generic copaxone isn't material for Pfizer and Synthon is private.

From Pfizer's Q416

Q: Can you also give us a roadmap for what biosimilar launches Pfizer might have in the next two to three years? And comment on your copaxone ANDA status in light of the legal ruling?

A: In the relatively near term, we anticipate that in the 2018, 2019 timeframe we'll be able to file around about five biosimilar products. I think you're aware of the products that we have in our pipeline.



Anyone have anything to add? Thanks